Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

CGTN: Čína dosiahla „veľké a rozhodujúce" víťazstvo v reakcii na ochorenie COVID-19: vedenie KSČ
  • Latin America - español
  • USA - español
  • USA - Pусский
  • USA - Deutsch
  • Brazil - Português
  • USA - English
  • USA - English
  • USA - Français
  • USA - čeština
  • Middle East - Arabic
  • USA - Polski


News provided by

CGTN

Feb 17, 2023, 11:22 ET

Share this article

Share toX

Share this article

Share toX

PEKING, 17. februára 2023 /PRNewswire/ -- Počas uplynulých troch rokov Čína vždy kládla na prvé miesto životy a zdravie ľudí a prispôsobila svoju reakciu na ochorenie COVID-19 vyvíjajúcej sa situácii, čím podľa všeobecného názoru získala drahocenný čas na hladký prechod.

Krajina dosiahla od novembra 2022 veľké a rozhodujúce víťazstvo vo svojej prevencii a kontrole ochorenia COVID-19, uviedol na štvrtkovom zasadnutí Stály výbor politického byra Ústredného výboru komunistickej strany Číny (KSČ).

Bolo preukázané, že hlavný úsudok, politické rozhodnutie a úprava stratégie KSČ v súvislosti s ochorením COVID-19 sú úplne správne, zaznelo na zasadnutí, ktorému predsedal generálny tajomník Ústredného výboru KSČ Si Ťin-pching.

„Tieto opatrenia sú účinné. Ľudia ich uznávajú. A úspech je obrovský," uviedol.

„Zázrak"

Čína od novembra 2022 neustále optimalizuje a upravuje svoje preventívne a kontrolné opatrenia proti ochoreniu COVID-19 so zameraním na ochranu zdravia ľudí a prevenciu závažných prípadov.

V rámci zásadného posunu vo svojich politikách reagovania začala krajina od 8. januára 2023 zvládať ochorenie COVID-19 s opatreniami určenými na boj proti infekčným chorobám triedy B namiesto infekčných chorôb triedy A.

Na štvrtkovom zasadnutí sa konštatovalo, že Čína v relatívne krátkom čase dosiahla stabilný prechod vo fázach prevencie a kontroly epidémie.

Vďaka tomu, že od novembra dostalo lekárske ošetrenie viac ako 200 miliónov ľudí a takmer 800 000 vážne chorých pacientov sa účinne vyliečilo, Čína si udržiava svoje miery úmrtnosti na COVID-19 medzi najnižšími na svete.

„Dosiahli sme veľké a rozhodujúce víťazstvo v oblasti prevencie a kontroly epidémie, čím sme vytvorili zázrak v histórii ľudskej civilizácie, v ktorom sa krajina s obrovskou populáciou úspešne spamätáva z pandémie," bolo uvedené na zasadnutí.

Nová fáza

Keďže reakcia Číny na ochorenie COVID-19 vstupuje do novej fázy, krajina urýchľuje úsilie o konsolidáciu toho, čo sa v priebehu rokov dosiahlo v boji proti pandémii COVID-19.

Na zasadnutí vedenia KSČ bolo zdôraznené, že je dôležité posilniť kapacitu monitorovania epidémie a zlepšiť systémy pravidelného včasného varovania vytvorením vhodného mechanizmu dohľadu a podávania správ.

Zasadnutie tiež vyzvalo na úsilie o vypracovanie vedeckého plánu pre ďalšiu fázu očkovania, najmä na zvýšenie zaočkovanosti starších ľudí.

Vzhľadom na vyvíjajúce sa kmene ochorenia COVID-19 Čína tiež zintenzívnila celoštátnu propagáciu posilňujúcich dávok. Podľa aktualizovaného akčného plánu vydaného spoločným mechanizmom prevencie a kontroly ochorenia COVID-19 Štátnej rady je v súčasnosti k dispozícii deväť kombinácií posilňujúcich vakcín vyvinutých rôznymi technickými spôsobmi vrátane vakcín poskytujúcich dobrú krížovú imunitu proti kmeňu Omikron.

Na štvrtkovom zasadnutí bolo tiež zdôraznené úsilie o zaručenie výroby a dodávok zdravotníckeho materiálu a zlepšenie mechanizmu ich koordinovaného nasadenia.

Na záver zasadnutia bolo uvedené, že je tiež potrebné vynaložiť úsilie na koordinovaný pokrok v oblasti vedeckých a technologických objavov v zdravotníctve a na zlepšenie úrovne vedy a techniky v oblasti života a zdravia.

https://news.cgtn.com/news/2023-02-16/Xi-chairs-CPC-leadership-meeting-on-latest-COVID-19-response-1htrVJOaUBW/index.html 

21%

more press release views with 
Request a Demo

Modal title

Also from this source

CGTN: Čína a Jižní Korea zintenzivní výměnu zkušeností v oblasti péče o ženy a děti

CGTN zveřejnila článek zaměřený na zintenzivnění výměny zkušeností mezi Čínou a Korejskou republikou v oblasti péče o ženy a děti. Článek, který...

CGTN: China und ROK wollen den Austausch über das Wohlergehen von Frauen und Kindern verstärken

CGTN hat einen Artikel veröffentlicht, der sich auf den verstärkten Austausch zwischen China und der Republik Korea im Bereich des Wohlergehens von...

More Releases From This Source

Explore

Publishing & Information Services

Publishing & Information Services

Computer & Electronics

Computer & Electronics

Multimedia & Internet

Multimedia & Internet

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.